Wednesday, August 31, 2011

VA, PTSD, & Risperdal: Age Of Aquarius STUPIDITY Continues

After 10 Years of poisoning our Vets with Risperdal for being Officially BILLED as 'Ideationally PTSD Broken & Disposable', ....... by Quacks who've never Cured Jack, and those same Quacks having Witnessed 1st hand & in person that their Risperdal was No Better Than Placebo at mitigating Their Opinion of an 'Incurable Illness', ...... our Veterans Administration is pursuing the Same, Psychiatric Stupid it has enshrined as its Official "Triumph of Hope Over Experience" with Risperdal for the drug's Primary, On Label Indication of Schizophrenia.

Yes, the VA is going to buy even More of this Brain Damaging Neurotoxin in their Cover Fiction that if they just Keep Poisoning people with it, Somehow, When Their Moon is in the Seventh House and Jupiter aligns with Mars*, They & their New Age Science's Peace will Guide the Planets and Love will Steer the Stars Concurring MARXIST, psychiatric parasites** will Someday, achieve at least ONE, ....... Positive, Ideation.

** parasite |ˈparəˌsīt|noun: an organism that lives in or on another organism (its host) and benefits by deriving nutrients at the host's expense.derogatory a person who habitually relies on or exploits others and gives nothing in return. Parasites exist in huge variety, including animals, plants, and microorganisms. They may live as ectoparasites on the surface of the host (e.g., arthropods such as ticks, mites, lice, fleas, and many insects infesting plants) or as endoparasites in the gut or tissues (e.g., many kinds of worm), and cause varying degrees of damage or disease to the host.ORIGIN mid 16th cent.: via Latin from Greek parasitos ‘(person) eating at another's table,’ from para- ‘alongside’ + sitos ‘food.’

parasite: noun: she longed to be free of the parasites in her family: hanger on, cadger, leech, passenger; informal: bloodsucker, sponger, bottom feeder, scrounger,freeloader, mooch.

NextGov has;

this is the fourteenth story in an ongoing series.

The Veterans Affairs Department continues to issue contracts to purchase an anti-psychotic drug to treat post-traumatic stress disorder despite research showing the drug, risperidone, is no more effective than a placebo.

Nextgov reported Aug. 22 that VA spent $717 million over the past decade to purchase risperidone, the generic name for Risperdal, asecond-generation anti-psychotic drug originally developed by the Janssen Pharmaceuticals division of Johnson & Johnson to treat severe mental conditions such as schizophrenia and bipolar disorder.

VA doctors prescribe the drug to treat PTSD, but a study by department researchers published Aug. 2 in the Journal of the American Medical Association concluded, "treatment with risperidone compared with placebo did not reduce PTSD symptoms."

Despite these findings, on Aug. 11, VA awarded a contract to Mylan Pharmaceuticals Inc. for more than 200,000 bottles of risperidone containing more than 20 million pills in multiple dosages. The announcement of the contract to the Morgantown, W.V., generic drug manufacturer did not provide a dollar value for the contract.

The Defense Department, Indian Health Service and Bureau of Prisons also can order off the Mylan contract, which has four option years.

The contract with Mylan is just one of more than 90 Federal Supply Schedule contracts for risperidone that VA has with other generic drug manufacturers and Janssen, according to the department's onlinepharmaceutical catalog.

The Food and Drug Administration has approved risperidone only for treatment of schizophrenia, bipolar disorder, and irritability associated with autistic disorder in children and adolescents, but clinicians can prescribe it for other conditions, a practice known as "off-label" use.

Janssen is under investigations by the Justice Department and several state attorneys general for its sales and marketing practices regarding Risperdal, according to Johnson & Johnson's quarterly report filed July 3 with the Securities and Exchange Commission.

A 2007 paper by two VA doctors who examined the marketing of second-generation anti-psychotic drugs provides insight into sales practices that contribute to such drugs' off-label use.

The paper, co-authored by Dr. Robert Rosenheck, a psychiatrist at the West Haven, Conn., VA medical center, reported that 639 department psychiatrists who responded to a Web survey said they were contacted an average of 14 times per year by pharmaceutical sales representatives, and were invited to attend continuing medical education seminars conducted by the companies.

Rosenheck, who also co-authored the Aug. 2 study on risperidone, reported that only half the assertions made by pharmaceutical sales representatives were consistent with FDA-approved labeling. "These findings suggest that there have been substantial discrepancies between information clinicians report having received in their contacts with industry representatives and FDA-approved information," he wrote.

Stay up-to-date with federal technology news alerts and analysis - sign up for Nextgov's email newsletters.

Thank You NextGov, & a Hat Tip to Involuntary Transformation for pointing this, yet One More Reason why Government Healthcare is a Rotten idea, out.

photo cred to RCA

No comments: